Rich, Sheldon J <br/><br/>
Shortcomings in pharmacy benefit forecasting--interferon beta products.  [electronic resource] 

 -  Journal of managed care pharmacy : JMCP   
 - 373; author reply 374 p.  digital 
<br/><br/> Publication Type: Comment; Letter 
<br/><br/><label>ISSN: </label>1083-4087 
<br/><br/><label>Standard No.: </label>10.18553/jmcp.2003.9.4.373  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--economics<br/>Cost-Benefit Analysis<br/>Humans<br/>Interferon beta-1a<br/>Interferon-beta--economics<br/>Multiple Sclerosis--drug therapy